Tica Valeria, Hanif M Wasim, Andersson Annika, Valsamakis G, Barnett A H, Kumar Sudesh, Sanjeevi C B
Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden.
Ann N Y Acad Sci. 2003 Nov;1005:356-8. doi: 10.1196/annals.1288.058.
The aims of our study were to measure autoantibodies to glutamic acid decarboxylase and autoantibodies to protein tyrosine phosphatase in patients with type 2 diabetes mellitus, patients with impaired glucose tolerance, and healthy controls of Asian origin from Birmingham, United Kingdom. According to our findings, 27% (9/33) of patients initially diagnosed with type 2 diabetes mellitus carry autoantibodies to GAD65.